The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients
Clinical trial NCT04701606 · UNKNOWN
Trial details
- NCT number
- NCT04701606
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2022-04-15
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.